Indian prodigy boy completes PhD in physics at the age of 21

Bangalore, Aug 28 (ANI): After creating waves by completing Bachelors’ degree at the age of 10 and Masters at 12, Tathagat Avatar Tulsi, well known as child prodigy has achieved another milestone by becoming a PhD in Physics.

He has completed his doctorate in Physics at the age of 21 from the Indian Institute of Science (IISc) in Bangalore, spending six years like anyone else.

Tulsi has the special distinction of being one of the world’s youngest scientists.

He credited his family members especially his father for helping him achieve the feat.

“Of course, there is some gift part there. I cannot ignore that because not all six-year-old boys are that sharp in Maths and have that kind of memory, which I had. So I think that there was a gift and I feel very lucky that I got proper environment in terms of my family members particularly my father. He did his best to encourage my talent,” said Tulsi.

The young Indian scientist has an invite from the Institute for Quantum Computing at the University of Waterloo, Canada, for post- doctoral work.

But he wants to continue his research in software development for quantum computing, the super fast future of number crunching in India given a chance and proper funding.

He said that he hopes to set up his own quantum computing company someday and is working hard for it.

Tulsi got a place for himself in the Guinness Book of World Records for holding MSc in physics from Patna University, at the age of 12 years and 2 months in 1999.

A native of Bihar, he was born into a lower middle-class family on September 9, 1987. His over ambitious parents wanted him to finish studies at the very young age to break all the world records.

Apart from spending his time amid an array of computers, Tulsi likes to play badminton, snookers, billiards and loves to listen to music. (ANI)

MRI methods can show bone marrow stem cells’ viability as brain-repairing therapy

Washington, August 20 (ANI): Researchers at Tel Aviv University have offered new hope for people with incurable neurodegenerative diseases like Huntington’s, Alzheimer’s, and Parkinson’s by showing that the viability of stem cells created from a patient’s own bone marrow can be determined using MRI tracking methods.

Dr. Yoram Cohen, of TAU’s School of Chemistry, claims that he has been able to track the progress of the innovative cells called mesenchymal stem cells within the brain.

He says that initial studies indicate that it is possible to identify unhealthy or damaged tissues, migrate to them, and potentially repair or halt cell degeneration.

“By monitoring the motion of these cells, you get information about how viable they are, and how they can benefit the tissue. We have been able to prove that these stem cells travel within the brain, and only travel where they are needed. They read the chemical signalling of the tissue, which indicate areas of stress. And then they go and try to repair the situation,” he says.

During the study, Dr. Cohen and his colleagues tracked the activity of the live cells within the brain using the in-vivo MRI at the Strauss Centre for Computational Neuro-Imaging, with a view to establishing their viability as a therapy for neurodegenerative disease.

The researchers used magnetic iron oxide nanoparticles to label the stem cells, so that they could be identified as clear black dots on an MRI picture after being injected into the brain.

The stem cells were then injected into the brain of an animal that had an experimental model of Huntington’s disease, which suffered from a similar neuropathology as the one seen in human patients.

On MRI, it was possible to watch the stem cells migrating towards the diseased area of the brain.

“Cells that go toward a certain position that needs to be rescued are the best indirect proof that they are live and viable. If they can migrate towards the target, they are alive and can read chemical signalling,” says Dr. Cohen.

He believes that the benefits of using differentiated mesenchymal cells (MSC) may be numerous.

“Bone marrow-derived MSCs bypass ethical and production complications, and in the long run, the cells are less likely to be rejected because they come from the patients themselves. This means you don’t need immunosuppressant therapy,” he says.

Dr. Cohen has revealed that the next step in his research will be to develop a real-life therapy for those suffering from neurodegenerative diseases.

A researcher article on his study has been published in the journal Stem Cells. (ANI)

Tripura Education University – Tripura University Exam Results – Tripura University Results 2009 – Tripura University MA, MSc & MCom Merit List -www.tripurauniversity.in

Tripura Education University – Tripura University Exam Results – Tripura University Results 2009 – Tripura University MA, MSc & MCom Merit List -www.tripurauniversity.in

Tripura University has declared provisional selected (second) list of candidates for admission to M.A, M.Sc, M.Com programmes for the academic year 2009.

This provisional list is available on Tripura University Website – http://www.tripurauniversity.in/

Direct Link to Tripura University MA, MSc & MCom Merit List -

http://www.tripurauniversity.in/2nd_list070709.pdf

Bundelkhand University ~ Bundelkhand University Exam Results ~ Bundelkhand University 2009 Results And Marks ~ www.bujhansi.org

Bundelkhand University ~ Bundelkhand University Exam Results ~ Bundelkhand University 2009 Results And Marks ~ www.bujhansi.org

Bundelkhand University, has declared BA-I, BA-II, BA-III, BEd, BHSc-I, BHSc-II, BHSc-III, BSc(AG)-II, BSc(AG)-III, BCom-I, BCom-II, BCom-III, BSc-III, MCom-I, MCom-II, MA(Home-Science)-II, MA (Maths)-II, MA(Economics)-I, MA(Economics)-II, MA(Sociology)-I, MA(Sociology)-II, MA(Music)-I, MA(Music)-II, MA(Political Science)-I, MA(Political Science)-II, MA(Geography)-I, MA(Geography)-II, MA(English)-I, MA(English)-II, MA(Hindi)-I, MA(Hindi)-II, MA(History)-I, MA(History)-II, MA(Sanskrit)-I, MA(Sanskrit)-II, MA (Psychology)-I, MA (Psychology)-II, MSc(Botany)-II, MSc(Chemistry)-II, MSc(Physics)-II, MSc(Zoology)-II Results.

These Results are available on Bundelkhand University Website – www.bujhansi.org

Direct Link to Results – http://www.bujhansi.org/_acad/_resu/marks.asp

Madras University ~ Madras University Education Results ~ 2009 Madras University Results ~ Madras University Revaluation Results 2009 ~ www.unom.ac.in ~ Chennai University ~ Chennai University Results ~ Chennai University 2009 Results

Madras University ~ Madras University Education Results ~ 2009 Madras University Results ~ Madras University Revaluation Results 2009 ~ www.unom.ac.in ~ Chennai University ~ Chennai University Results ~ Chennai University 2009 Results

Madras University has declared revaluation results of MBA, MCA and MSc (IT) degree courses 2009.

These results are available on Madras University Website – http://www.unom.ac.in/

Direct Link to Results – http://results.unom.ac.in/mba_mca_msc-it.html

Contact Details :

University of Madras
Chepauk, Chennai-600 005,
Tamil Nadu, South India
Fax: 91-44-25367654

Madras University ~ Madras University 2009 Education Result ~ Madras University Results 2009 ~ Madras University Revaluation 2009 Result~ www.unom.ac.in

Madras University ~ Madras University 2009 Education Result ~ Madras University Results 2009 ~ Madras University Revaluation 2009 Result~ www.unom.ac.in

Madras University has declared revaluation results of MBA, MCA and MSc (IT) degree courses 2009.

These results are available on Madras University Website – http://www.unom.ac.in/

Direct Link to Results – http://results.unom.ac.in/mba_mca_msc-it.html

Non-invasive stem cell procedure shows promise to repair heart tissue

Washington, May 29 (ANI): For the first time, researchers at the University at Buffalo have shown that it is possible to repair cardiac tissue and, in turn, reverse heart failure by injecting adult bone marrow stem cells into skeletal muscle.

The researchers used an animal model to demonstrate that the non-invasive procedure could increase myocytes, or heart cells, by two-fold and reduce cardiac tissue injury by 60 percent.

In addition, the therapy improved function of the left ventricle-the primary pumping chamber of the heart-by 40 percent.

It even reduced fibrosis-the hardening of the heart lining that impairs its ability to contract-by up to 50 percent.

“This work demonstrates a novel non-invasive mesenchymal stem cell (MSC) therapeutic regimen for heart failure based on an intramuscular delivery route,” said Dr. Techung Lee, UB associate professor of biochemistry and senior author on the paper.

Mesenchymal stem cells are found in the bone marrow, and can differentiate into a variety of cell types.

Lee said: “Injecting MSCs or factors released by MSCs improved ventricular function, promoted myocardial regeneration, lessened apoptosis (cell death) and fibrotic remodeling, recruited bone marrow progenitor cells and induced myocardial expression of multiple growth factor genes.

“These findings highlight the critical ‘cross-talks’ between the injected MSCs and host tissues, culminating in effective cardiac repair for the failing heart.

“An important feature of MSCs is their ability to produce a plethora of tissue healing effects, known as “tropic factors,” which can be harnessed for stem cell therapy for heart failure.

The multiple trophic factors produced by MSCs have already been shown to be capable of reducing tissue injury, inhibiting fibrosis, promoting angiogenesis, stimulating recruitment and proliferation of tissue stem cells, and reducing inflammatory oxidative stress, a common cause of cardiovascular disease and heart failure.

Lee added: “Since skeletal muscle is the most abundant tissue in the body and can withstand repeated injection of large number of stem cells, we thought it would be a good method to deliver MSCs. We hypothesized that MSCs, via secretion of these functionally synergistic trophic factors, would be able to rescue the failing heart even when delivered away from the myocardium.

“This study proves our hypothesis. We’ve demonstrated that injecting MSCs, or trophic factors released by MSCs, into skeletal muscle improved ventricular function, promoted regeneration of heart tissue, decreased cell death and improved other factors that cause heart failure.

“This non-invasive stem cell administration regimen, if validated clinically, is expected to facilitate future stem cell therapy for heart failure.”

The development has been reported in a paper appearing online in the Articles-in-Press section of the American Journal of Physiology-Heart Circulation Physiology. (ANI)

Lieutenant General Avinash Chander Soneja posted as DG of OL and SM

New Delhi, Mar 30 (ANI): Lieutenant General Avinash Chander Soneja, an alumnus of the Sainik School, Kapurthala, has been posted as Director General of Operational Logistics and Strategic Movement at Integrated HQ of Ministry of Defence (Army), New Delhi.

The General Officer had joined Sainik School, Kapurthala (Punjab), in January 1963.

A graduate of the Defence Services Staff College, Wellington, he had attended the prestigious higher command course at Indian Army’s War College, Mhow.

He holds Post Graduate degrees in MSc and M Phil (Defence Studies) and MBA (HRD). He has held numerous command and staff appointments including the General Officer Commanding, Counter Insurgency Force (Romeo) in Jammu and Kashmir.

The General Officer has been decorated with the Ati Vishisht Seva Medal and twice with Vishist Seva Medal for his outstanding performance.

The General Officer is married. His wife Neelam Soneja is a school teacher and the couple have two children. (ANI)

Family history linked to increased blood clot risk

Washington, Mar 24 (ANI): Children and siblings of people with venous thrombosis, or blood clots in the veins, may be more than twice as likely to develop the condition than those without a family history, say Dutch researchers.

Venous thrombosis typically begins in leg veins, although the clot may subsequently break off and travel to the lungs.

“Because universal screening is not cost-effective, research efforts are focused on selection criteria that may be used to increase the chance of finding a genetic risk factor,” the authors write.

“Family history is an evident candidate,” they added.

To reach the conclusion, Irene D. Bezemer, M.Sc., and colleagues at Leiden University Medical Center, Leiden, the Netherlands, collected blood samples and information about family history and environmental risk factors from 1,605 patients who had experienced their first clot between 1999 and 2004.

Their data was compared with that of 2,159 control participants who were the same sex and age but had not had venous thrombosis.

Among patients with venous thrombosis, 505 (31.5 percent) had at least one first-degree relative with a history of the condition, compared with 373 controls (17.3 percent). A positive family history was associated with a more than two-fold increase in the risk of venous thrombosis; the risk was increased further if the relative developed clots at a younger age and as much as quadrupled if more than one relative was affected.

Family history did not correspond well with known genetic risk factors, suggesting that there may be unknown genetic risk factors or that venous thrombosis may cluster in a family due to characteristics of the shared household, the authors note.

“Both in those with and without genetic or environmental risk factors, family history remained associated with venous thrombosis,” the authors write.

“The risk increased with the number of factors identified; for those with a genetic and environmental risk factor and a positive family history, the risk was about 64-fold higher than for those with no known risk factor and a negative family history,” they added.

The relative risk associated with family history was similar to that associated with a genetic risk factor.

The study has been published in the March 23 issue of Archives of Internal Medicine, one of the JAMA/Archives journals. (ANI)

Motor control exercises lower persistent low back pain

Washington, Jan 29 (ANI): A new study has revealed that motor control exercises, when performed along with other forms of therapy, can significantly alleviate persistent low back pain.

According to the researchers, these exercises not only reduce pain, but patients are more physically active and experience positive effects over a longer period of time.

“Although the exercises seemed promising, until now we did not have clear evidence on whether or not they were more effective,” said researcher Luciana G Macedo, PT, MSc, a PhD student at The George Institute for International Health in Sydney, Australia.

The motor control exercise, also known as specific stabilization exercise, is a new form of exercise for back pain, which focuses on regaining control of the trunk muscles, which support and control the spine.

“It is important to note that this form of exercise is different from going to the gym or going for a walk,” said Macedo.

“The program relies upon a skilled clinician, such as a physical therapist, identifying the specific trunk muscles that are a problem and then working closely with patients to teach them how to get the muscles working properly again.

“The patient first learns to control these muscles in simple postures, then later in more challenging activities. The ultimate goal is for the patient to get the muscles to work to control and support the spine in those activities that previously caused pain,” she added.

The new systematic review published in the January issue of Physical Therapy (PTJ), the scientific journal of the American Physical Therapy Association (APTA). (ANI)